Flynn Pharma Ltd

Alton House, 4 Herbert Street, Dublin 2, Republic of Ireland,
Telephone: +44 (0)1438 727822
Fax: +44 (0)1438 727805
WWW: http://www.flynnpharma.com
Medical Information Direct Line: +44 (0)1438 727822
Medical Information e-mail: medinfo@flynnpharma.com
Customer Care direct line: +44 (0)1773 510 123
Medical Information Fax: +44 (0)1438 727805

Summary of Product Characteristics last updated on the eMC: 07/09/2009
SPC Cefuroxime Sodium Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/09/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 6. 3 - Shelf Life
Date of revision of text on the SPC:   19-Jan-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

To increase shelf life to 3 years
Updated on 19/07/2006 and displayed until 07/09/2009
Reasons for adding or updating:
  • Change to section 6. 3 - Shelf Life
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 10 (date of (partial) revision of the text
Date of revision of text on the SPC:   07/2006
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 6.3 - Extension in shelf life from 18 months to 24 months.
 
Section 6.5 - Addition of a 10 pack.
Updated on 30/09/2005 and displayed until 19/07/2006
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
  • SPC Submitted in error

Active Ingredients/Generics

 
   cefuroxime sodium